HDAC9 and breast carcinoma: This is also a precondition in terms of the future development of effective HDAC inhibitors that could suppress the action of HDACs and express efficient anti-tumor activity, hence paving the way for novel therapeutic approaches in (triple negative) breast cancer treatment.